Several Plaintiffs have asked the Judicial Panel on Multidistrict Litigation to create a Bausch & Lamb ReNu contact lens solution MDL.
Petitons were filed April 28, 2006. They claim that actions regarding injury, consumer claims, and medical monitoring, as to ReNu® MoistureLoc Contact Lens Solution should be transferred and consolidated.
Suggested sites are: The U.S. District Courts for the Western District of Louisiana, the Southern District of Florida and the Eastern District of New York as the most appropriate venues.
The Issues relating to the contact lens soltuion are:
On April 10, the FDA and the CDC alerted healthcare professionals and their patients of the increasing number of reports of the rare but serious fungal eye infection, which can cause blindness. Three days later, Bausch & Lomb requested that U.S. retailers stop selling ReNu. The FDA issued a statement on April 14 supporting the company’s decision to temporarily withdraw its product, the plaintiffs say, noting that symptoms of fungal keratitis include eye pain and discomfort, vision loss and light hypersensitivity.
